| Drug
Watch International is a volunteer non-profit drug information network
and advocacy organization that promotes the creation of healthy drug-free
cultures in the world and opposes the legalization of drugs.
The organization upholds a comprehensive approach to drug issues
involving prevention, education, intervention/treatment, and law enforcement/interdiction.
Drug Watch International is comprised
of a Board of Directors, state and international Delegates,
a Liaison Network of representatives from
international, national, and state prevention and treatment organizations,
Council of Advisors, and the International
Drug Strategy Institute.
The purpose of Drug Watch
International is to provide policymakers, the media, and the public with
current information, factual research, expert resources, and to counter drug
advocacy propaganda.
|
Drug Watch Says Goodbye to an Old Friend
Otto Moulton's Courage Never Failed nor Faltered
Click here to read the article
News Notes
Almost 10% of first-year college students at a mid-Atlantic university have a cannabis use disorder, and 38.4% of those who used
marijuana five or more times in the past year reported potentially serious cannabis-related problems.
("Addictive Behaviors" 33(3):397-411, March 2008: CESAR Fax 1/21/2008)
On March 17, 1999, the Institute of Medicine (IOM) released its report, "Marijuana and Medicine: Assessing
the Science Base." At a news conference on that date, Principal Investigators John A. Benson and Stanley J.
Watson Jr., commented:
(Benson) "It is important to stress that the goal of these trials should not be to develop marijuana as a
licensed drug. Rather, these trials should be done in parallel with the development of new, safe delivery
systems of drugs related to the compounds found in marijuana."
(Watson) "Marijuana's future as medicine does not involve smoking. It involves exploiting the potential in
cannabinoids such as THC, the key psychoactive ingredient of marijuana."
Click here for Institute of Medicine Report Recommendations.
Click here for the Statement from the FDA
Copyright © 2001-2003 Drug Watch International. All rights reserved. Disclaimer
Please address all comments and questions to: Drug Watch International, P.O. Box
45218, Omaha, NE 68145-0218, USA
Telephone: 402-384-9212
*AOL* users should click on the "Refresh" button in their browser window to insure that the newest web page is being displayed.
